The pharmacology of antimyoclonic drugs

Clinical Neuroscience

Volumn 3, Issue 4, 1995, Pages 246-252

  Pranzatelli, Michael R ^a  

^a National Pédiatrie Myoclonus Center ^*  (United States)

Author keywords

antimyoclonic drugs; GABA; glutamate; glycine; myoclonus; serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; GLYCINE; SEROTONIN;

ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; MYOCLONUS; NEUROTRANSMISSION; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; TREATMENT PLANNING;

ANTICONVULSANTS; GABA AGENTS; HUMANS; MYOCLONUS; NEUROTRANSMITTER AGENTS; RECEPTORS, GLUTAMATE; RECEPTORS, GLYCINE; SEROTONIN AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029521416     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Artieda J, Obeso JA , (1993): The pathophysiology and pharmacology of photic cortical reflex myoclonus. Ann Neurol 34:175-184.
2. Baldino F Jr, Geller HM , (1981): Sodium valproate enhancement of γ-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity. J Pharmacol Exp Ther 217:445-450.
3. Decker C-M , (1992): Convulsants acting at the inhibitory glycine receptor. In Herken H, Hurter F (eds): "Handbook of Experimental Pharmacology, Selective Neurotoxicity," Vol 102. Berlin: Springer Verlag.
4. Betz H , (1992): Structure and function of inhibitory glycine receptors. Q Rev Biophys 25:381-394.
5. Bowery NG , (1993): GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol 33:109-147.
6. Carlen PL, Gurevich N, Davies MF, Blaxter TJ, O'Beirne M , (1985): Enhanced neuronal K conductance: A possible common mechanism for sedative-hypnotic drug action. Can J Physiol Pharmacol 63:831-537.
7. Chapman AG , (1986): Valproate and myoclonus. Adv Neurol 43:661-674.
8. DeLorenzo RJ , (1984): Calmodulin systems in neuronal excitability: A molecular approach to epilepsy. Ann Neurol 16(Suppl):104-114.
9. DeLorey TM, Kissin I, Brown P, Brown GB , (1993): Barbiturate-benzodiazepine interactions at the gamma-aminobutyric acid A receptor in rat cerebral cortical synaptoneurosomes. Anesth Analg 77: 598-605.
10. Doble A, Martin IL , (1992): Multiple benzodiazepine receptors: No reason for anxiety. TIPS 13:76-81.
11. Donevan SD, Rogawski MA , (1993): GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10:51-59.
12. Edwards E, Whitaker-Azmitia PM , (1987): Selective β-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus. Neuropharmacology 26: 93-96.
13. Fariello R, Smith MC , (1989): Valproate. Mechanisms of action. In Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE (eds): "Antiepileptic Drugs," 3rd Ed. New York: Raven Press, pp 267-282.
14. Foster AC, Kemp JA , (1989): HA-966 antagonizes N-methyl-D-aspartate receptions through a selective interaction with the glycine modulatory site. J Neurosci 9:2191-3001.
15. Giurgea C, Salama M , (1977): Nootropic drugs. Progr Neuropsychopharmacol Biol Psychiatry 1:235-247.
16. Gouliaev AH, Senning A , (1994): Piracetam and other structurally related nootropics. Brain Res Rev 19:180-222.
17. Gowen AJ, Noyer M, Verloes R, Gobert J, Wulfert E , (1992): UCB L059, a novel anticonvulsant drug: Pharmacological profile in animals. Eur J Pharmacol 222:193-203.
18. Haefely W , (1989): Benzodiazepines. Mechanisms of action. In Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE (eds): "Antiepileptic Drugs," 3rd Ed. New York: Raven Press, pp 267-282.
19. Hollmann M, Heinemann S , (1994): Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
20. Homan RW, Rosenberg HC , (1993): Benzodiazepines. In Wyllie E(ed): "The Treatment of Epilepsy: Principles and Practices." Philadelphia: Lea and Febiger, pp 932-985.
21. Hoyer D, Schoeffler P , (1991): 5-HT receptors: Subtypes and second messengers. J Receptor Res 11:197-214.
22. Knoflach F, Drescher U, Scheurer L, Malherbe P, Mohler H , (1993): Füll and partial antagonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. J Pharmacol Exp Ther 266:385-391.
23. Lang DG, Wang CM, Cooper BR , (1993): Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 266:829-835.
24. Leach MJ, Marden CM, Miller AA , (1986): Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II: Neurochemical studies on the mechanism of action. Epilepsia 27:490-497.
25. Leppik IE, Graves N, Devinsky O , (1993): New antiepileptic medications. Epilepsy I: Diagnosis and treatment. Neurol Clin 11:923-949.
26. Lipton SA, Rosenberg PA , (1994): Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med
27. Löscher W, Honack D, Taylor CP , (1991): GABApentin increases aminooxyacetic acid-induced GABA accumulation in different regions of rat brain. Neurosci Lett 128:150-154.
28. Macdonald RL, Olsen RW , (1994): GABA receptor channels. Annu Rev Neurosci 17:569-602.
29. Manaker S, Rainbow TC, Winokur A , (1986): Thyrotropin-releasing hormone (TRH) receptors: Localization in rat and human central nervous system. In: "Quantitative Receptor Autoradiography." New York: Alan R. Liss, Inc., pp 103-135.
30. McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR , (1993): Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J Pharmacol Exp Ther 264:1248-1252.
31. Meldrum BS , (1994): The role of glutamate in epilepsy and other CNS disorders. Neurology 44(Suppl 8):S14-S23.
32. Mervoala E, Andermann F, Quesney LF, Krelina M , (1990): Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies. Neurology 40:53-56.
33. Metcalf BW, Sjoerdsma A, et al, . (1981): Suicide inhibition of GABA transaminase. In Singer T, Ondarza PN (eds): "Molecular Basis of Drug Action." Amsterdam: Elsevier, pp 119-131.
34. Metcalf G , (1982): Regulatory peptides as a source of new drugs-The clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res Rev 4:389-4108.
35. Miller LG, Greenblatt DJ, Barnhill JG, Shader RI , (1988): Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor down regulation and decreased gamma-aminobutyric acid A receptor function. J Pharmacol Exp Ther 246:170176.
36. Morselli PL, Lloyd KG , (1985): Mechanism of action of antiepileptic drugs. In Porter J, Morselli PL (eds): "The Epilepsies." London: Butterworth, pp 40-81.
37. Niclsen EB, Suzdak PD, Andersen KE, Knutsen LJ, Sonnewald U, Braestrup C , (1991): Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur J Pharmacol 196:257-266.
38. Olsen RW, Leelo-Lundbery F , (1981): Convulsant and anticonvulsant drug binding sites related to GABA-regulated chloride ion channels. In Costa E, DiChiara G, Cessa G (eds): "GABA and Benzodiazepine Receptors." Adv Biochem Psychopharmacol, Vol 26. New York: Raven Press, pp 93-102.
39. Palmer GC, Murray RJ, Wilson TCM, Eisman MS, Ray RK, Griffith RC, Napier JJ, Fedorchuk M, Stagnitto ML, Garske GE , (1991): Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide. Epilepsy Res 12:9-20.
40. Pasternak GW , (1993): Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
41. Poisson M, Huguet F, Savattier A, BakriLogeais F, Narcisse G , (1984): A new type of anticonvulsant, stiripentol: Pharmacological profile and neurochemical study. Arzneim-Forsch Drug Res 34:199204. .
42. Pole P, Bonetti EP, Schaffner R, Haefely W , (1983): A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines, and phenobarbitone. Naunyn-Schmiedebergs Arch Pharmacol 321:260-264.
43. Pranzatelli MR , (1991): Regional central serotonin receptor binding in rats treated chronically with high-dose 5-hydroxy-L-tryptophan. Exp Brain Res 87: 340-344.
44. Pranzatelli MR , (1994): Serotonin and human myoclonus: Rationale for the use of serotonin receptor agonists and antagonists. Arch Neurol 50:1-11.
45. Pranzatelli MR , (1996): Antidyskinetic drug therapy for pédiatrie movement disorders. J Child Neurol (in press).
46. Pranzatelli MR, Nadi NS , (1995): Mechanism of action of antiepileptic and antimyoclonic drugs. Adv Neurol 67: 329-360.
47. Ransom RW , (1991): Polyamine and ifenprodil interactions with the NMDA receptor's glycine site. Eur J Pharmacol 208:67-71.
48. Receptor and Ion Channel Nomenclature Supplement , (1994): Trends Pharmacol Sei 15:1-48.
49. Richards JG, Möhler H , (1984): Benzodiazepine receptors. Neuropharmacology 23:233-12.
50. Roba J, Cavalier R, Cordi A, et al, . (1986): Milacemide. In Meldrum BS, Porter RJ (eds): "New Anticonvulsant Drugs. Current Problems in Epilepsy." London: John Libbey, pp 179-190.
51. Saudou F, Hen R , (1994): 5-Hydroxytryptamine receptor subtypes: Molecular and functional diversity. Adv Pharmacol 30:327-380.
52. Schmutz M, Portet C, Jeker A, Klebs K , (1990): The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn-Schmiedebergs Arch Pharmacol 342:61-66.
53. Seeburg PH , (1993): The TIPS/TINS lecture: The molecular biology of mammalian glutamate receptor channels. TIPS 14: 298-303.
54. Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell IP, Wasmuth JJ , (1993): Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet 5:351-358.
55. Strange PG , (1993): Dopamine receptors in the basal ganglia: Relevance to Parkinson's disease. Movement Disord 8:263270.
56. Suman-Chauhan N, Webdale L, Hill DR, Woodruff GN , (1993): Characterization of [3H]GABA-pentin binding to a novel site in rat brain: Homogenate binding studies. Eur J Pharmacol 15:293-301.
57. Tacconi MT, Wurtman RJ , (1986): Piracetam: Physiological disposition and mechanism of action. Adv Neurol 43: 675-684.
58. Trimble MR, Robertson MM , (1986): Clobazam. In Meldrum BS, Porter RJ (eds): "New Anticonvulsant Drugs." London: John Libbey, pp 65-85.
59. Watabe S, Yoshii M, Ogata N, Tsunoo A, Narahashi T , (1993): Differential inhibition of transient and long-lasting calcium channel currents by benzodiazepines in neuroblastoma cells. Brain Res 606:244-250.